Literature DB >> 26178557

Primary hyperoxaluria type 1 diagnosed after kidney transplantation: The importance of pre-transplantation metabolic screening in recurrent urolithiasis.

GholamHossein Naderi1, Firouzeh Tabassomi, AmirHossein Latif, MohammadReza Ganji.   

Abstract

Entities:  

Year:  2015        PMID： 26178557     DOI： 10.4103/1319-2442.160216

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN： 1319-2442


× No keyword cloud information.
  5 in total

Review 1.  Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries.

Authors:  Jamsheer Jehangir Talati; Sally-Anne Hulton; Sander F Garrelfs; Wajahat Aziz; Shoaib Rao; Amanullah Memon; Zafar Nazir; Raziuddin Biyabani; Saqib Qazi; Iqbal Azam; Aysha Habib Khan; Jamil Ahmed; Lena Jafri; Mohammad Zeeshan
Journal:  Urolithiasis       Date:  2017-06-28       Impact factor: 3.436

2.  The Long-term Outcome of Pediatric Kidney Transplantation in Iran: Results of a 25-year Single-Center Cohort Study.

Authors:  G Naderi; A Latif; S Karimi; F Tabassomi; S T Esfahani
Journal:  Int J Organ Transplant Med       Date:  2017-05-01

3.  Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review.

Authors:  Ruiming Cai; Minzhuang Lin; Zhiyong Chen; Yongtong Lai; Xianen Huang; Guozhi Zhao; Xuekun Guo; Zhongtang Xiong; Juan Chen; Hui Chen; Qingping Jiang; Shaoyan Liu; Yuexin Yang; Weixiang Liang; Minhui Zou; Tao Liu; Wenfang Chen; Hongzhou Liu; Juan Peng
Journal:  BMC Nephrol       Date:  2019-06-18       Impact factor: 2.388

Review 4.  Primary hyperoxaluria diagnosed after kidney transplantation: a case report and literature review.

Authors:  Zhitao Cai; Mao Ding; Rengui Chen; Jiefu Zhu; Lian Li; Xiongfei Wu
Journal:  BMC Nephrol       Date:  2021-11-27       Impact factor: 2.388

Review 5.  Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss.

Authors:  Hillarey K Stone; Katherine VandenHeuvel; Alexander Bondoc; Francisco X Flores; David K Hooper; Charles D Varnell
Journal:  Am J Transplant       Date:  2021-07-29       Impact factor: 8.086
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.